Inquire Before Buying - Colorectal Cancer (CRC) Diagnostics and Treatments Market Report, 2030

Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Research Report: Forecast (2025-2030)

Colorectal Cancer (CRC) Diagnostics and Treatments Market - By Diagnosis (Blood & Stool Tests, Imaging, Biopsy, Flexible Sigmoidoscopy, Colonoscopy), By Treatment (Chemotherapy (Al......kylating Agents, Antimetabolites (Fluorouracil, Capecitabine), Others), Immunotherapy (Monoclonal Antibodies (Bevacizumab, Cetuximab, Panitumumab), Biologic Response Modifiers, Colony-Stimulating Factors, Tumor Vaccines), Surgery, Targeted Therapy, Others (Radiofrequency Ablation (RFA), etc.)), By End-User (Hospitals, Specialty Clinics, Others (Ambulatory Surgery Centers, etc.)) and Others Read more

Healthcare
Feb 2025
Pages 195
Report Format: PDF, Excel, PPT

Market Definition

Colorectal cancer (CRC) is a type of cancer that often begins as polyps, which are abnormal growths in the colon or rectum. If not addressed, it has the potential to spread to other areas of the body. As one of the most common cancers globally, colorectal cancer boasts a high survival and treatment success rate when identified in its early stages.

Market Insights & Analysis: Global Colorectal Cancer (CRC) Diagnostics and Treatments Market (2025-30)

The Global Colorectal Cancer (CRC) Diagnostics and Treatments Market size was valued at around USD10.89 Billion in 2024 and is projected to reach USD16.89 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.6% during the forecast period, i.e., 2025-30.

This market expansion is linked to several factors. The market for colorectal cancer diagnosis and treatment is being greatly boosted by the growth of specialty cancer hospitals around the world. For instance, to enhance local cancer care in Kerala, India opened a six-story cancer specialty block at Ernakulam General Hospital in October 2023. The building has 105 beds contemporary amenities, an intensive care unit, and a chemotherapy unit. To address the growing need for specialized CRC care in the area KLE Society in Belagavi, opened a state-of-the-art 300-bed cancer hospital in December 2024. The facility offers everything from robotic surgery to bone marrow transplants. Herb Chambers donated USD 100 million to Massachusetts General Hospital (USA) in December 2024 so that they could construct a new tower that would allow patients, including those with colorectal cancer to receive more centralized cancer care services.

Report Coverage	Details
Historical Years	2020-23
Base Years	2024
Forecast Years	2025-30
Market Value in 2024	USD10.89 Billion
Market Value in 2030	USD16.89 Billion
CAGR (2025-30)	7.6%
Leading Region	North America
Top Key Players	Abbott Laboratories, Amgen Inc., Bayer AG, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Pfizer Inc
Key Report Highlights	Market Dimensions & Projections Pricing Evaluation, Recent Strategic Moves by Companies, Primary Stakeholders, Analysis of Import and Export Trends, Competitive Landscape Assessment, Emerging Opportunities, Market Trends and Indicators

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

In the United States 2024, Cardinal Health paid USD 1.12 billion to acquire Integrated Oncology Network, expanding its oncology network to over 100 healthcare providers in 10 states. This move increased the accessibility of specialized oncology services for patients with colorectal cancer. These noteworthy advancements show a global dedication to enhancing cancer care systems which will boost the markets for CRC diagnosis and treatment.

For its early detection & intervention, CRC is being diagnosed by government-led screening programs. This has boosted the global market. To enhance its screening for populations with low screening rates, particularly those aged 45 to 75, the Center for Disease Control and Prevention started a cooperative agreement in the United States in 2024. The goal of this program is to collaborate with primary care clinics and health systems to create evidence-based interventions for this population. Similarly, Taiwan’s Health Promotion Administration started implementing free biennial fecal immunochemical testing (FIT) for people aged 45–74 years in January 2025. This is to promote early diagnosis and lower the mortality rates associated with colorectal cancer. By encouraging proactive screening methods, these government policies support global efforts to prevent colorectal cancer, which in turn drives demand for diagnostics and treatments.

New opportunities for market consideration have been presented by the home testing kit that will boost the industry’s growth. A significant shift has occurred in recent years toward non-invasive test kits that enable the general public to perform the test at home with ease. This trend is majorly growing in North America due to the increased demand for at-home testing. Cologuard Plus is one such kind of FDA-approved test kit developed by Exact Sciences that allows people to collect stool samples & test them for the early detection of colorectal cancer (CRC). The rationale for using the kit includes accuracy and a growing understanding of the importance of early cancer detection. Home testing kits will help increase the rate of early CRC detection, which will reduce healthcare costs and improve patient outcomes in CRC management. This contributes to influencing market dynamics and generating significant growth shortly.

Introduction
1. Research Process
2. Assumption
3. Market Segmentation
4. Market Definition
Executive Summary
Global Colorectal Cancer (CRC) Market Trends & Insights
Global Colorectal Cancer (CRC) Market Regulation & Policy, By Country
Global Colorectal Cancer (CRC) Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Colorectal Cancer (CRC) Market Hotspot and Opportunities
Global Colorectal Cancer (CRC) Market Outlook, 2020- 2030
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
    1. Blood & Stool Tests
    2. Imaging
    3. Biopsy
    4. Flexible Sigmoidoscopy
    5. Colonoscopy
  2. By Treatment
    1. Chemotherapy
      1. Alkylating Agents
      2. Antimetabolites
        
        Fluorouracil
        
        Capecitabine
      3. Others
    2. Immunotherapy
      1. Monoclonal Antibodies
        
        Bevacizumab
        
        Cetuximab
        
        Panitumumab
      2. Biologic Response Modifiers
      3. Colony-Stimulating Factors
      4. Tumor Vaccines
    3. Surgery
    4. Targeted Therapy
    5. Others (Radiofrequency Ablation (RFA), etc.)
  3. By End-User
    1. Hospitals
    2. Specialty Clinics
    3. Others (Ambulatory Surgery Centers, etc.)
  4. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Competition Characteristics
    2. Revenue Shares
    3. Competitor Placement in MarkNtel Advisor’s Quadrant
North America Colorectal Cancer (CRC) Market Outlook, 2020- 2030
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The US
    2. Canada
    3. Mexico
South America Colorectal Cancer (CRC) Market Outlook, 2020- 2030
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. Brazil
    2. Rest of Latin America
Europe Colorectal Cancer (CRC) Market Outlook, 2020- 2030
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
Middle East & Africa Colorectal Cancer (CRC) Market Outlook, 2020- 2030
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. South Africa
    2. GCC
    3. Rest of Middle East & Africa
Asia-Pacific Colorectal Cancer (CRC) Market Outlook, 2020- 2030
1. Market Size and Analysis
  1. By Revenues in USD Million
2. Market Share and Analysis
  1. By Diagnosis
  2. By Treatment
  3. By End-User
  4. By Country
    1. China
    2. Japan
    3. India
    4. Australia
    5. South East Asia
    6. Rest of Asia-Pacific
Global Colorectal Cancer (CRC) Market Key Strategic Imperatives for Success and Growth
Competitive Outlook
1. Competition Matrix
  1. By Application Portfolio
  2. Brand Specialization
  3. Target Markets
  4. Target by Applications
  5. Research & Development
  6. Strategic Alliances
  7. Strategic Initiatives
2. Company Profiles (Business Description, By Application Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Abbott Laboratories
  2. Amgen Inc.
  3. Bayer AG
  4. Bristol Myers Squibb
  5. Eli Lilly and Company
  6. GlaxoSmithKline PLC
  7. F. Hoffmann-La Roche AG
  8. Merck & Co., Inc.
  9. Novartis International AG
  10. Pfizer Inc.
  11. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *